Welcome to our dedicated page for Molina Hlthcare SEC filings (Ticker: MOH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to SEC filings for Molina Healthcare, Inc. (NYSE: MOH), a FORTUNE 500 company that provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. These regulatory documents offer detailed insight into how Molina reports its operations, capital structure, and material events.
Among the key filings are Form 8-K current reports, where Molina discloses material developments. Recent 8-Ks describe the private offering of 6.500% Senior Notes due 2031, including interest terms, maturity, ranking, redemption features, and the related indenture. Other 8-Ks outline a new revolving credit facility, amendments to the company’s credit agreement, and a delayed draw term loan used to partially fund a stock repurchase program.
Additional 8-K filings furnish earnings releases for specific quarters, summarizing premium revenue, total revenue, net income, medical care costs, medical care ratios, and segment performance for Medicaid, Medicare, and marketplace operations. These reports also include reconciliations of non-GAAP measures such as adjusted net income, EBITDA, and Adjusted EBITDA, along with explanations of how these metrics are calculated and their limitations.
Investors can also review filings that discuss Medicaid and CHIP contract developments, such as the Notice of Agency Decision indicating an intent to award Molina Healthcare of Florida a Statewide Medicaid Managed Care and Children’s Health Insurance Program contract for the Children’s Medical Services Program. These documents help explain how new or renewed contracts may affect membership and premium revenue.
On Stock Titan, Molina Healthcare’s filings are updated as they are released on EDGAR, and AI-powered summaries highlight the main terms, financial impacts, and segment implications of each document. This allows users to quickly understand complex credit agreements, debt offerings, and earnings disclosures without reading every page of the underlying filing.
T. Rowe Price Associates, Inc. reported beneficial ownership of 994,260 shares of Molina Healthcare Inc. common stock, representing 1.9% of the class as of 12/31/2025. The firm is organized in Maryland.
T. Rowe Price has sole power to vote 991,424 shares and sole power to dispose of 994,260 shares, with no shared voting or dispositive power. It states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Molina Healthcare.
Capital World Investors has disclosed a significant ownership stake in Molina Healthcare, Inc. The investment firm reports beneficial ownership of 3,511,197 shares of Molina Healthcare common stock, representing 6.8% of the company’s 51,400,000 shares believed to be outstanding as of the reported date.
Capital World Investors, a division of Capital Research and Management Company and its affiliated investment management entities, reports sole voting power over 3,510,147 shares and sole dispositive power over 3,511,197 shares, with no shared voting or dispositive power. The shares are certified as being held in the ordinary course of business and not for the purpose of changing or influencing control of Molina Healthcare.
Molina Healthcare, Inc. director Richard C. Zoretic reported an indirect open-market purchase of company stock through a trust associated with him. On 02/11/2026, the Richard Charles Zoretic Revocable Living Trust bought 800 shares of Molina Healthcare common stock at $125.16 per share.
Following this transaction, the trust beneficially owns 8,747 shares of Molina Healthcare common stock, all reported as indirect ownership by Zoretic.
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC report a passive stake in Molina Healthcare, Inc. They beneficially own 410,403 shares of Molina common stock, representing 0.8% of the outstanding class as of 12/31/2025, with shared voting and dispositive power over all reported shares.
The firms certify the position is held in the ordinary course of business and not for changing or influencing control of Molina Healthcare. The filing also notes that AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC, and both entities jointly file this Schedule 13G/A.
Molina Healthcare, Inc. reports 2025 results showing strong top-line growth but sharply lower earnings in a challenging government-paid healthcare environment. Total revenue rose to
Premium revenue reached
The company outlines a strategy focused on government-sponsored programs, targeting
Molina Healthcare, Inc. amended its credit agreement on February 4, 2026, temporarily easing a key debt covenant. The required minimum quarterly interest coverage ratio was reduced from 3.00:1.00 to 1.75:1.00 for quarters ending March 31 through December 31, 2026, then stepped up to 2.00:1.00 for March 31, 2027, 2.50:1.00 for June 30, 2027, and 2.75:1.00 for September 30, 2027.
The company also determined on February 5, 2026 that it will record an estimated non-cash, pre-tax impairment charge of approximately $93 million in the first quarter of 2026, tied to certain intangible assets. This follows a decision to exit its Medicare Advantage Prescription Drug product for 2027 to focus exclusively on dual eligible Medicare members. The charge will be recorded outside of adjusted net income.
Molina Healthcare, Inc. filed a current report stating that it issued a press release with its financial results for the fourth quarter and year ended December 31, 2025, as well as full-year 2026 revenue and earnings guidance.
The press release is provided as Exhibit 99.1 to the report, and any information on the company’s website referenced in that release is expressly excluded from being part of this report.
FMR LLC filed a Schedule 13G reporting beneficial ownership of 2,969,387.80 shares of Molina Healthcare common stock, representing 5.8% of the class as of 12/31/2025. FMR LLC reports sole voting power over 2,802,222.73 shares and sole dispositive power over 2,969,387.80 shares.
Abigail P. Johnson is also a reporting person, with sole dispositive power over 2,969,387.80 shares and no voting power. The filing states the shares were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control, other than activities solely in connection with a nomination under Rule 240.14a-11.
One or more other persons may receive dividends or sale proceeds from these shares, but no such person holds more than five percent of Molina Healthcare’s common stock.
BlackRock, Inc. has filed an amended Schedule 13G reporting beneficial ownership of Molina Healthcare common stock as of December 31, 2025. BlackRock reports beneficial ownership of 3,524,452 shares of Molina Healthcare, representing 6.9% of the outstanding common stock.
BlackRock has sole voting power over 3,296,986 shares and sole dispositive power over 3,524,452 shares, with no shared voting or dispositive power. The stake is held through various BlackRock business units and underlying clients, and no single other person has an interest in more than five percent of Molina’s outstanding common shares. BlackRock certifies that the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Molina Healthcare.
Molina Healthcare director reports quarterly stock grant under equity plan
A director of Molina Healthcare, Inc. received a grant of 317 shares of common stock on January 1, 2026 under the company’s 2025 Equity Incentive Plan, in connection with service as a director. The grant value was based on an annual equity award of $220,000 per director, with one quarter, or $55,000, granted on the first day of each quarter.
Because January 1, 2026 was a non-trading day, the share amount was calculated using the $173.54 closing price of Molina Healthcare common stock on December 31, 2025. Following this transaction, the reporting person beneficially owned 17,325 shares held by a family trust and 1,500 shares held in the reporting person’s 401(k) plan, all reported as indirect ownership.